Nevada · GLP-1 Telehealth
REMEVi connects Nevada residents with licensed bilingual providers for semaglutide and tirzepatide prescriptions. No insurance required. Free shipping to Las Vegas, Henderson, Reno, and all of Nevada.
Why Nevada
Built for Nevada's tourism workforce, growing population, and bilingual community.
Many Nevada workers in tourism, hospitality, and the gig economy lack employer-sponsored insurance. REMEVi's direct-pay model fits.
29% of Nevada is Hispanic. All REMEVi care is fully available in English and Spanish — built for Nevada's bilingual workforce.
From the Las Vegas Strip to Reno and rural northern Nevada — REMEVi serves every city and town with free shipping.
Every REMEVi licensed provider holds an active Nevada medical license and follows Nevada State Board of Medical Examiners standards.
How it works
Three simple steps. Bilingual throughout.
Answer a few medical questions from your phone. English or Spanish.
A Nevada-licensed clinician reviews your history and confirms candidacy within 24 hours.
Free, discreet shipping to any Nevada address in 3–5 business days.
Statewide
REMEVi ships to every ZIP code in Nevada. Major cities include:
Nevada is roughly 29% Hispanic, with a heavily tourism-dependent economy that means many workers go without employer health insurance. REMEVi's direct-pay, bilingual model was built for exactly this.
Medications
Compounded semaglutide and tirzepatide from FDA-registered 503B pharmacies.
$149 first month, then $279/mo
A once-weekly GLP-1 injection, with monthly dose adjustments guided by your provider.
Learn more →$249 first month, then $379/mo*
A dual GLP-1 + GIP receptor agonist, linked to higher average weight loss.
Learn more →Pricing
Pay monthly or commit for significant savings. All-inclusive — medication, clinical review, and shipping.
One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
FAQ
All of Nevada — Las Vegas, Henderson, North Las Vegas, Reno, Sparks, Carson City, and beyond.
Yes. All REMEVi services are bilingual — English and Spanish.
Yes. All licensed providers hold active Nevada medical licenses. As of July 2026, 213 clinicians in the REMEVi clinical network hold an active Nevada license.
No. REMEVi is a direct-pay service — $149 for your first month, then $279/month. It's designed for the many Nevada workers without employer-sponsored coverage.
Explore REMEVi's online GLP-1 care by city:
Free 1-minute quiz, then a 5-minute intake if you qualify. Nevada-licensed clinical review within 24 hours. Free shipping statewide.
See if you qualify — $149 first monthFree · no card required
